KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Imax (IMAX) Liabilities and Shareholders Equity (2016 - 2025)

Imax's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $894.0 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 7.66% year-over-year to $894.0 million; the TTM value through Dec 2025 reached $3.5 billion, up 5.14%, while the annual FY2025 figure was $894.0 million, 7.66% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $894.0 million at Imax, up from $889.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $942.4 million in Q1 2021 and bottomed at $800.2 million in Q3 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $847.9 million (2024), against an average of $849.3 million.
  • The largest annual shift saw Liabilities and Shareholders Equity fell 16.92% in 2021 before it rose 7.66% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $883.2 million in 2021, then fell by 7.03% to $821.2 million in 2022, then fell by 0.79% to $814.7 million in 2023, then rose by 1.93% to $830.4 million in 2024, then grew by 7.66% to $894.0 million in 2025.
  • Per Business Quant, the three most recent readings for IMAX's Liabilities and Shareholders Equity are $894.0 million (Q4 2025), $889.6 million (Q3 2025), and $868.6 million (Q2 2025).